Meissa Vaccines has appointed Frank Glavin as chief executive officer. Co-founder Dr. Martin Moore will serve as chief scientific officer of the company, which develops vaccines for respiratory viruses.

“We are at an important stage in Meissa’s growth, and Frank brings extensive, complementary experience in commercial planning, business development and pipeline strategy to advance novel technologies in clinical development for regulatory approval,” Moore said in a statement.

Glavin was previously CEO of Orphan Technologies and head of Neovii Biotech North America.